Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Academic Drug Discovery

Stuart Farrow's Biography

Stuart Farrow, Director of Biology, Cancer Research Technology

Stuart joined CRT as director of biology in April 2015. Before joining CRT he spent more than 20 years in drug discovery and leadership roles in the pharmaceutical industry. Most recently he was based at the University of Manchester, where he directed the establishment of the Manchester centre for collaborative research in inflammation and immunology (MCCIR), a £15M initiative funded by GSK, AstraZeneca and the University of Manchester. He is currently a member of the UK MRC Infection and Immunity Board. Stuart has worked in several therapeutic areas, and has also directed major translational research initiatives. He has published extensively in the inflammation, immunology and apoptosis areas.

Stuart Farrow Image

Beyond Checkpoint Inhibitors, New Opportunities In Immuno-Oncology

Tuesday, 7 March 2017 at 11:45

Add to Calendar ▼2017-03-07 11:45:002017-03-07 12:45:00Europe/LondonBeyond Checkpoint Inhibitors, New Opportunities In

This presentation will explore opportunities for the full potential of the immune system to be exploited to treat cancer, building on the recent transformational success with the current generation of T-cell targeted checkpoint antibodies, and suggest that immune tolerance will become a unifying concept with implications across a large range of disease areas.

Add to Calendar ▼2017-03-06 00:00:002017-03-07 00:00:00Europe/LondonAcademic Drug